We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

87 hedge funds and large institutions have $14.1M invested in Zomedica Corp. in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 10

5% less funds holding

Funds holding: 92 → 87 (-5)

28% less capital invested

Capital invested by funds: $19.5M → $14.1M (-$5.43M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
87
Holders Change
-5
Holders Change %
-5.43%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
20
Reduced
10
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$59.9K
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$38.7K
3
BBHC
Brown Brothers Harriman & Co
New York
+$35.1K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$29.8K
5
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$10.5K

Top Sellers

Rank Fund Capital Flow
1
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$2.16M
2
BlackRock
BlackRock
New York
-$218K
3
TSS
Two Sigma Securities
New York
-$74.4K
4
Squarepoint
Squarepoint
New York
-$63.9K
5
SCA
Snowden Capital Advisors
New York
-$47.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$8.16M – – –
BlackRock
2
BlackRock
New York
$1.74M -$218K -1,120,374 -10%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.61M +$59.9K +308,492 +3%
State Street
4
State Street
Massachusetts
$555K – – –
ProShare Advisors
5
ProShare Advisors
Maryland
$499K +$7.45K +38,380 +1%
BBHC
6
Brown Brothers Harriman & Co
New York
$412K +$35.1K +181,000 +8%
Northern Trust
7
Northern Trust
Illinois
$299K +$4.46K +22,954 +1%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$82K +$29.8K +153,400 +46%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$72.9K – – –
Charles Schwab
10
Charles Schwab
California
$68.9K – – –
BCI
11
Brinker Capital Investments
Pennsylvania
$59.7K – – –
OPS
12
Orion Portfolio Solutions
Nebraska
$59.7K – – –
GT
13
Glenmede Trust
Pennsylvania
$40.6K – – –
Fidelity Investments
14
Fidelity Investments
Massachusetts
$36.8K +$38.7K +199,328 +942%
Commonwealth Equity Services
15
Commonwealth Equity Services
Massachusetts
$36K +$268 +1,380 +0.6%
Morgan Stanley
16
Morgan Stanley
New York
$34.2K -$6.97K -35,915 -15%
Cambridge Investment Research Advisors
17
Cambridge Investment Research Advisors
Iowa
$22K -$2.16M -11,128,480 -99%
SPC
18
Sigma Planning Corp
Michigan
$19.1K +$7.77K +39,999 +54%
Victory Capital Management
19
Victory Capital Management
Texas
$17.8K +$77 +396 +0.4%
CAN
20
Cetera Advisor Networks
California
$15.2K – – –
ASN
21
Advisory Services Network
Georgia
$14.1K +$4.86K +25,000 +42%
RhumbLine Advisers
22
RhumbLine Advisers
Massachusetts
$11.7K – – –
I
23
INVST
Indiana
$11.4K – – –
SOS
24
Silver Oak Securities
Tennessee
$9.82K – – –
CIBC Private Wealth Group
25
CIBC Private Wealth Group
Georgia
$9.02K +$10.5K +54,000 New
1
2 3 4

ZOM Hedge Fund Activity: Q3 2023 in Review

87 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2023, worth a combined $14.1M — down 28% from $19.5M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of ZOM and 8 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 20 added.

The largest buyer was Geode Capital Management, adding an estimated $59.9K. The largest seller was Cambridge Investment Research Advisors, cutting an estimated $2.16M.

  • 87 institutional investors held Zomedica Corp. (ZOM) as of Q3 2023, down from 92 in Q2 2023.
  • Funds reported $14.1M of Zomedica Corp. stock for Q3 2023, down 28% quarter-over-quarter.
  • 8 funds opened new Zomedica Corp. positions in Q3 2023 and 13 closed out, a net change of -5 holders.
  • The largest Zomedica Corp. buyer in Q3 2023 was Geode Capital Management, an estimated $59.9K added.
  • The largest Zomedica Corp. seller in Q3 2023 was Cambridge Investment Research Advisors, an estimated $2.16M sold.

Based on aggregated 13F filings for Q3 2023.